GB1051230A - - Google Patents

Info

Publication number
GB1051230A
GB1051230A GB1051230DA GB1051230A GB 1051230 A GB1051230 A GB 1051230A GB 1051230D A GB1051230D A GB 1051230DA GB 1051230 A GB1051230 A GB 1051230A
Authority
GB
United Kingdom
Prior art keywords
aromatic ring
compositions
membered
aug
unsaturated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of GB1051230A publication Critical patent/GB1051230A/en
Active legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1,051,230. Blood-pressure lowering compositions. DR. KARL THOMAE G.m.b.H. Aug. 18, 1965 [Aug. 18, 1964], No. 35468/65. Heading A5B. [Also in Division C3] Pharmaceutical compositions having bloodpressure lowering activity contain as active ingredient condensation products consisting predominantly of recurring units: in which R' is a hydrogen atom or a saturated or unsaturated, branched or unbranched aliphatic hydrocarbon group which may be phenyl substituted; Ar represents a 6-membered carbocyclic aromatic ring or a 6-membered heterocyclic aromatic ring containing 1 or 2 nitrogen atoms which may be fused to a 6-membered carbocyclic aromatic ring and/or is substituted by a C 1 -C 3 alkyl group or by phenyl (e.g. a benzene, byridine, pyrimidine, pyrazine or quinoline nucleaus); M is a bivalent saturated or unsaturated, branched or unbranched C 1 -C 19 aliphatic hydrocarbon group which may contain a bivalent 6-membered alicyclic group or a heteroatom, e.g. sulphur. Acid addition salts, e.g. with camphoric, mandelic or pamoic (see Specification 990,481) acid, may be used. The compositions may be presented in a form suitable for oral, rectal or parenteral (including intravenous) administration, using conventional pharmaceutical carriers or excipients. They may be formulated as dosage units in the form of tablets, coated tablets, lozenges, ampoules and suppositories.
GB1051230D 1964-08-18 Active GB1051230A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DET0026842 1964-08-18

Publications (1)

Publication Number Publication Date
GB1051230A true GB1051230A (en)

Family

ID=7553077

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1051230D Active GB1051230A (en) 1964-08-18

Country Status (1)

Country Link
GB (1) GB1051230A (en)

Similar Documents

Publication Publication Date Title
GB940596A (en) ยช -hydrazino acids
GB1153578A (en) Phenyl-Isopropylamine Derivatives
GB1296544A (en)
GB1256750A (en)
GB1174051A (en) Aminophenol Derivatives and Analgesic and Antipyretic Compositions
GB1448026A (en) 2-aminomethyleneindanone analgesic agents
GB1178242A (en) Novel Biologically Active Bis-Isothioureas
GB1265279A (en)
GB1051230A (en)
GB1229400A (en)
GB1131164A (en) Novel halogen-substituted tetrahydroquinazoline derivatives, their preparation and compositions containing them
GB1174349A (en) Novel 2-Anilinomethylimidazoline Derivatives and process for the preparation thereof
GB1250353A (en)
GB971243A (en) Substituted 4-phenylaminoquinolines
GB1195319A (en) Alkyl Sulfate Salts of 1-(p-Chlorobenzhydryl)-4-Methylhomopiperazines
GB1245711A (en) Phenethyl alcohols
GB1254270A (en) Benzoxazepine derivatives
SE300011B (en)
GB1245155A (en) NOVEL 5-SUBSTITUTED-gamma-CARBOLINE DERIVATIVES AND THE SALTS THEREOF
GB1271519A (en) Improvements in or relating to derivatives of phloroglucinol
GB1276719A (en) Benzomorphan derivatives and their salts
GB1173636A (en) Alkyl Phenylpiperazinylalkylcarbamates
GB1113802A (en) Improvements in or relating to substituted quinolines and the manufacture thereof
GB1390091A (en) 4-4-biphenylyl-butyric acid derivatives
GB969027A (en) Tetrahydrodibenzazocines